Author: PanGIA Biotech

PanGIA Biotech Non-Invasive Cancer Detection Abstracts Accepted for Presentation at AACR Annual Meeting 2026

May 21, 2026
PanGIA Biotech Announces Peer-Reviewed Study in Diagnostics Showing 97.8% Sensitivity in Detecting Prostate Cancer Using a Urine-Based Liquid Biopsy with Machine Learning

May 20, 2026

PanGIA Biotech Non-Invasive Cancer Detection Abstracts Accepted for Presentation at AACR Annual Meeting 2026